How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Negligence Claim Market
- By Claim Type: Surgical Errors, Misdiagnosis or Delayed Diagnosis, Medication Errors, Birth Injuries, Anesthesia Errors, Hospital Negligence
- By Claimant Type: Individual Patients, Class Action Groups, Healthcare Professionals, Family Members of Deceased Patients
- By Legal Outcome: Settlements, Court Judgments, Arbitration Awards, Dismissed Claims
- By Healthcare Setting: Hospitals, Outpatient Clinics, Nursing Homes, Dental Practices, Pharmacies
- By Damages Claimed: Compensatory Damages, Punitive Damages, Economic Loss, Non-Economic Loss (Pain and Suffering)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Surgical Errors leads By Claim Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Medical Negligence Claim Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Claim Type 6
Claimant Type 4
Legal Outcome 4
Healthcare Setting 5
Damages Claimed 4
Companies profiled
LegalZoom
Avvo (part of Martindale-Avvo)
Irwin Mitchell
Slater and Gordon
Leigh Day
Pannone Corporate LLP
Bolt Burdon Kemp
The Claim Partnership
Hodge Jones & Allen
Stewarts Law LLP
Irwin Mitchell LLP
Slater and Gordon Lawyers
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →LegalZoom
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Avvo (part of Martindale-Avvo)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Irwin Mitchell
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Slater and Gordon
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Leigh Day
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Pannone Corporate LLP
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Bolt Burdon Kemp
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →The Claim Partnership
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hodge Jones & Allen
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Stewarts Law LLP
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Irwin Mitchell LLP
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Slater and Gordon Lawyers
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Leigh Day Solicitors
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Bolt Burdon Kemp Solicitors
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$11,944M by 2033 · 11.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Surgical Errors39.7
- Misdiagnosis or Delayed Diagnosis9.1
- Medication Errors19.7
- Birth Injuries9.3
- Anesthesia Errors10.7
- Hospital Negligence11.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,629M → $4,006M · 11.9%
Europe$1,135M → $2,665M · 11.3%
Asia Pacific$1,037M → $2,489M · 11.6%
Latin America$641.7M → $1,615M · 12.2%
Middle East and Africa$493.6M → $1,164M · 11.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.622026
11.642027
11.652028
11.672029
11.672030
11.692031
11.712032
11.722033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- LegalZoom8.6
- Avvo (part of Martindale-Avvo)26.8
- Irwin Mitchell8.0
- Slater and Gordon8.9
- Leigh Day6.7
- Pannone Corporate LLP13.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Claim Type26.2%
Claimant Type28.4%
Legal Outcome11.6%
Healthcare Setting16.3%
Damages Claimed17.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe22.3
- Asia Pacific20.8
- Latin America13.5
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| LegalZoom | 94 | 83 | 81 | 98 | 89 | 80 | 88 |
| Avvo (part of Martindale-Avvo) | 89 | 84 | 91 | 86 | 74 | 70 | 82 |
| Irwin Mitchell | 74 | 76 | 65 | 82 | 86 | 75 | 76 |
| Slater and Gordon | 67 | 76 | 72 | 58 | 81 | 71 | 71 |
| Leigh Day | 66 | 66 | 55 | 53 | 65 | 65 | 62 |
| Pannone Corporate LLP | 57 | 53 | 65 | 63 | 58 | 48 | 57 |
| Bolt Burdon Kemp | 47 | 63 | 54 | 63 | 53 | 57 | 56 |
| The Claim Partnership | 47 | 43 | 36 | 53 | 46 | 40 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- LegalZoom
- Avvo (part of Martindale-Avvo)
- Irwin Mitchell
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| LegalZoom | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Avvo (part of Martindale-Avvo) | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Irwin Mitchell | ✓ | ✓ | − | ◐ | ✓ | ◐ |
| Slater and Gordon | ◐ | ✓ | ◐ | ◐ | ◐ | − |
| Leigh Day | ◐ | ◐ | − | − | ◐ | − |
| Pannone Corporate LLP | − | ◐ | ◐ | ◐ | − | ◐ |
| Bolt Burdon Kemp | − | − | − | ◐ | − | ◐ |
| The Claim Partnership | ◐ | ◐ | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1LegalZoom88
2Avvo (part of Martindale-Avvo)82
3Irwin Mitchell76
4Slater and Gordon71
5Leigh Day62
6Pannone Corporate LLP57
7Bolt Burdon Kemp56
8The Claim Partnership44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
LegalZoomAvvo (part of Martindale-Avvo)
Challenger2
Strong scale, closing on the leaders.
Irwin MitchellSlater and Gordon
Contender2
Focused players with pockets of strength.
Leigh DayPannone Corporate LLP
Niche2
Specialists in a single segment or region.
Bolt Burdon KempThe Claim Partnership
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Claim Type in North America, then scale across Medical Negligence Claim Market — a $85M beachhead inside a $1.46B market.
Beachhead (SOM)$85Mobtainable near-term
Serviceable (SAM)$575Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Surgical Errors
Best fit — highest urgency & budget in Claim Type.
Economic buyer78 fit
Misdiagnosis or Delayed Diagnosis
Strong fit — clear ROI and a fast path to value.
End user70 fit
Medication Errors
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Claim Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Claimant Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Legal Outcome
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Claim Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Negligence Claim Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation14%
Closed-won6%
$18.7KCAC
$90KLTV
4.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Negligence Claim Market is a durable-growth opportunity — $8.16B by 2033, compounding at 6.3%.
TAM · 2025$5.01Btoday
TAM · 2033$8.16Bforecast
CAGR6.3%2027–2033
Cumulative$58.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.16BTotal addressable market
SAM$3.21BServiceable available market
SOM$623MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.3% CAGR
Demand compounds through 2033, outpacing GDP across Claim Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Claim Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.16BLarge & growingTAM by 2033 at 6.3% CAGR
$3.21BServiceable nowreachable with today’s model
$623MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.36BBear4.1% CAGR
$8.16BBase6.3% CAGR
$10.4BBull8.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Claimant Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Negligence Claim Market — a $4.82B market by 2033. Plan: grow share from 5.6% to 11.6%.
Market size · 2033$4.82Btotal addressable
Market CAGR7.7%2027–2033
Target share11.6%from 5.6% today
Revenue ambition$559Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.6% | 11.6% | Ahead |
| Revenue | $257M | $559M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 32.7% | 38.8% | On track |
| Customer retention | 89.2% | 93.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Claim Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Claimant Type capability
A defensible second engine — invest in Claimant Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Claim Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Claimant Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $60M capacity & capability investment
- Greenlight bolt-on M&A in Claimant Type
- Authorise North America expansion plan
- Fund R&D program for Claim Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Negligence Claim Market conversation — a $4.80B market you can size, segment and defend in minutes.
Market size · 2033$4.80Btotal opportunity
Growth9.6%CAGR to 2033
Addressable buyers1,491+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Claim Type
Goal Grow share in Claim Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 2 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
LegalZoomAvvo (part of Martindale-Avvo)Irwin MitchellSlater and GordonLeigh DayPannone Corporate LLPBolt Burdon KempThe Claim Partnership+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Negligence Claim Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Negligence Claim Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Medical Negative Pressure Wound Therapy (NPWT) Systems Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportMedical Negative Pressure Ventilator Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportMedical Negative Pressure Suction System Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportMedical Negative Pressure Suction Pump Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportMedical Negative Pressure Suction Devices Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportMedical Negative Pressure Isolation Chamber Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportMedical Negative Ion Oxygen Generator Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportMedical Needle Tester Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportMedical Needles Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportMedical Needle Packaging Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportMedical Needle-Free Syringe Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportMedical Needle-Free Injection Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.